Huang, R., & Tao, J. (2020). Nicotinamide mononucleotide attenuates glucocorticoid-induced osteogenic inhibition by regulating the SIRT1/PGC-1α signaling pathway. Molecular Medicine Reports, 22(1), 145. https://doi.org/10.3892/mmr.2020.11116
Chicago Style (17th ed.) CitationHuang, Rui-Xiong, and Jun Tao. "Nicotinamide Mononucleotide Attenuates Glucocorticoid-induced Osteogenic Inhibition by Regulating the SIRT1/PGC-1α Signaling Pathway." Molecular Medicine Reports 22, no. 1 (2020): 145. https://doi.org/10.3892/mmr.2020.11116.
MLA (9th ed.) CitationHuang, Rui-Xiong, and Jun Tao. "Nicotinamide Mononucleotide Attenuates Glucocorticoid-induced Osteogenic Inhibition by Regulating the SIRT1/PGC-1α Signaling Pathway." Molecular Medicine Reports, vol. 22, no. 1, 2020, p. 145, https://doi.org/10.3892/mmr.2020.11116.